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Background
Group 3a/b cephalosporins are currently being used in
the treatment of UTI and urosepsis. However, Extended
Spectrum Beta-Lactamase (ESBL) mediated resistance
has been increasingly reported among uropathogens
from HIV patients. We sought to determine the inci-
dence of ESBL genes- blaCTX-M, blaTEM and blaSHV
among E. coli isolates from HIV (with increased expo-
sure to cephalosporins) and non-HIV antenatal patients.
Methods
PCR detection of blaCTX-M, blaTEM and blaSHV were car-
ried out among ESBL producing urinary E. coli isolates
from HIV (n=57) and non-HIV antenatal patients
(n=22). Fisher’s exact test was employed to analyze the
statistical significance of the results.
Results
Overall, 31.7%, 59.5% of the E. coli isolates carried bla-
TEM, blaCTX-M respectively, while none harboured
blaSHV. When stratified based on host group, significant
difference was observed in the incidence of blaCTX-M
among the isolates from HIV and non-HIV patients
(70.2% vs 31.8% respectively, p = 0.0024; OR 5.042; 95%
CI = 1.7441-14.5759). Nonetheless, difference in preva-
lence of blaTEM among the HIV and non-HIV isolates
was not statistically significant (29.8% vs 36.4%, p =
0.5979). Co-occurrence of blaTEM and blaCTX-M was
detected among 22.8%, 0% of the E. coli isolates from
HIV and non-HIV patients respectively (OR 5.1447; 95%
CI = 1.3766-19.2273).
Conclusion
Our results augment the fact that frequent exposure to
cephalosporins serves as the driving selection force lead-
ing to increased incidence of ESBL (blaCTX-M) mediated
resistance among the E. coli isolates from HIV patients.
Hence, the risk associated with antimicrobial exposure
needs to be considered in therapeutic decision making.
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